{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T07:22:07Z","timestamp":1648797727681},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00347-020-01304-1","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T10:05:12Z","timestamp":1612433112000},"page":"96-97","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuronale Ceroid-Lipofuszinosen"],"prefix":"10.1007","volume":"118","author":[{"given":"M. S.","family":"Spitzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"1304_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13023-016-0414-2","volume":"11","author":"RD Geraets","year":"2016","unstructured":"Geraets\u00a0RD, Koh\u00a0S, Hastings\u00a0ML et\u00a0al (2016) Moving towards effective therapeutic strategies for neuronal ceroid lipofuscinosis. Orphanet J Rare Dis 11:40","journal-title":"Orphanet J Rare Dis"},{"key":"1304_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","volume":"15","author":"TB Johnson","year":"2019","unstructured":"Johnson\u00a0TB, Cain\u00a0JT, White\u00a0KA et\u00a0al (2019) Therapeutic landscape for Batten disease: current treatments and future prospects. Nat Rev Neurol 15:161\u2013178","journal-title":"Nat Rev Neurol"},{"key":"1304_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","volume":"33","author":"A Kohlsch\u00fctter","year":"2019","unstructured":"Kohlsch\u00fctter\u00a0A, Schulz\u00a0A, Bartsch\u00a0U et\u00a0al (2019) Current and emerging treatment strategies for neuronal ceroid lipofuscinoses. CNS Drugs 33:315\u2013325","journal-title":"CNS Drugs"},{"key":"1304_CR4","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","volume":"378","author":"A Schulz","year":"2018","unstructured":"Schulz\u00a0A, Ajayi\u00a0T, Specchio\u00a0N et\u00a0al (2018) Study of intraventricular cerliponase alfa for CLN2 disease. N\u00a0Engl J Med 378:1898\u20131907","journal-title":"N Engl J Med"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-020-01304-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T10:07:34Z","timestamp":1612433254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-020-01304-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1304"],"URL":"https:\/\/doi.org\/10.1007\/s00347-020-01304-1","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"11 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S.\u00a0Spitzer und U.\u00a0Bartsch geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}